← Back to Search

YES-ERACE Curriculum for Reducing Youth Violence (YES-ERACE Trial)

N/A
Recruiting
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (0 months), end of program (3 months), 6 months, 9 months, 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the YES-ERACE program, which helps middle school students from diverse backgrounds create projects to fight racism. By participating, students are expected to feel more empowered, develop better attitudes towards different races, and reduce violent behaviors.

Who is the study for?
This trial is for middle school students in grades 6-8 who are part of after-school programs at six schools within the Genesee County Intermediate School District. Participants must agree to join; those who don't or whose parents refuse cannot participate.
What is being tested?
The study tests YES-ERACE, an adapted curriculum aimed at empowering youth to tackle racism and reduce violence, against regular after-school activities. It measures how well it boosts empowerment, anti-racist behavior, and decreases violent acts among students.
What are the potential side effects?
Since this intervention involves educational programming rather than medical treatment, traditional side effects are not applicable. However, participants may experience changes in attitudes or behaviors related to race and empowerment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (0 months), end of program (3 months), 6 months, 9 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (0 months), end of program (3 months), 6 months, 9 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Bystander behaviors
Change in Privilege awareness
Change in Prosocial behaviors
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: YES-ERACEExperimental Treatment1 Intervention
Students participate in the YES-ERACE program.
Group II: ControlActive Control1 Intervention
Students participate in the regular after-school programming.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The YES-ERACE program empowers youth by involving them in designing and implementing community projects aimed at addressing racism and reducing violent behavior. Similar treatments work by enhancing youths' sense of empowerment, promoting positive social behaviors, and fostering a supportive community environment. These mechanisms are crucial as they help youth develop critical thinking, leadership skills, and a sense of agency, which can lead to long-term reductions in violence and improvements in community cohesion.
Testing the efficacy of a hospital-based violence intervention programme: protocol and design.A Preliminary Investigation of Ethnic Differences in Resistance in Multisystemic Therapy.From pioneers to scientists: challenges in establishing evidence-gathering models in torture and trauma mental health services for refugees.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,857 Previous Clinical Trials
6,436,846 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
436 Previous Clinical Trials
1,378,939 Total Patients Enrolled

Media Library

YES-ERACE Clinical Trial Eligibility Overview. Trial Name: NCT05337410 — N/A
Treatment Research Study Groups: YES-ERACE, Control
Treatment Clinical Trial 2023: YES-ERACE Highlights & Side Effects. Trial Name: NCT05337410 — N/A
YES-ERACE 2023 Treatment Timeline for Medical Study. Trial Name: NCT05337410 — N/A
~39 spots leftby Jun 2025